Welcome to the EyePoint Pharmaceuticals website. The information provided on this site is for general informational and educational purposes only. Please read and review these Terms and Conditions carefully before accessing or using this website.
Use of the EyePoint corporate website (the Site) is subject to the following terms and conditions, which may be changed by EyePoint from time to time. Users are responsible for regularly reviewing these terms and conditions. Continued use of this Site following any such changes shall constitute an acceptance of the new terms and conditions.
PLEASE READ THESE TERMS CAREFULLY AS USE OF THIS SITE CONSTITUTES AGREEMENT TO THESE TERMS AND CONDITIONS.
All product names, whether or not appearing in large print or with the trademark symbol, are trademarks of EyePoint, its affiliates, related companies, or its licensors or partners, unless otherwise noted. The use or misuse of these trademarks or any other materials, except as permitted herein, is expressly prohibited and may be in violation of copyright law, trademark law, the laws of slander and libel, the laws of privacy and publicity, and communications regulations and statutes. Please be advised that EyePoint actively and aggressively enforces its intellectual property rights to the fullest extent of the law. The entire contents of this Site are subject to copyright protection. The contents of this Site may not be copied other than for non-commercial individual reference with all copyright or other proprietary notices retained, and thereafter may not be recopied, reproduced or otherwise redistributed. Except as expressly provided above, you may not otherwise copy, display, download, distribute, modify, reproduce, republish, or retransmit any information, text, or documents contained in this Site or any portion thereof in any electronic medium or in hard copy, or create any derivative work based on such images, text, or documents, without the express written consent of EyePoint. Nothing contained herein shall be construed as conferring by implication, estoppel, or otherwise any license or right under any copyright, patent, trademark, or other intellectual property right of EyePoint or any third party.
This Site contains links to other websites that are not owned or operated by us. We do not warrant, represent, or assume any responsibility or liability for the operation or security of any such third-party sites, or for the accuracy or completeness of the information, software, or other materials on such sites or any other sites for which links are provided in such linked sites. Links to third-party sites on this Site are not referrals or endorsements by us of such linked sites. We recommend that you familiarize yourself with the notices and legal and other terms and conditions of such third-party linked sites.
You agree to indemnify, defend, and hold harmless EyePoint, its officers, directors, employees, and agents from and against all losses, expenses, damages, and costs, including reasonable attorneys’ fees, resulting from any violation by you of these Terms and Conditions.
This Site may contain general information relating to various medical conditions and their treatment. Such information is provided for informational purposes only and is not meant to be a substitute for advice provided by a doctor or other qualified healthcare professional. Patients should not use the information contained herein for diagnosing a health problem or disease. Patients should always consult with a doctor or other healthcare professional for medical advice or information about diagnosis and treatment. Non-Confidential Information. Any communication or other material that you send to us through the Internet or post on the Site by electronic mail or otherwise, such as any questions, comments, suggestions or the like, is and will be deemed to be non-confidential, and EyePoint shall have no obligation of any kind with respect to such information.
Various statements made on this website are forward-looking, within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, and are inherently subject to risks, uncertainties, and potentially inaccurate assumptions. All statements that address activities, events or developments that we intend, expect, plan or believe may occur in the future, including but not limited to statements about our potential to receive future payments from Alimera pursuant to our May 2023 sale and license agreement with Alimera; the sufficiency of our existing cash resources into 2025; our expectations regarding the timing and clinical development of our product candidates, including EYP-1901; the potential for EYP-1901 as a novel sustained delivery treatment for serious eye diseases, including wet age-related macular degeneration, non-proliferative diabetic retinopathy and diabetic macular edema; and our longer term financial and business goals and expectations, are forward-looking statements. Some of the factors that could cause actual results to differ materially from the anticipated results or other expectations expressed, anticipated or implied in our forward-looking statements are risks and uncertainties inherent in our business including, without limitation: the effectiveness and timeliness of clinical trials, and the usefulness of the data; the timeliness of regulatory approvals; our ability to access needed capital; our ability to successfully manufacture sufficient quantities of YUTIQ® pursuant to our supply agreements with Alimera and Ocumension Therapeutics; the success of current and future license agreements, including our agreements with Alimera, Ocumension Therapeutics, Equinox Science and Betta Pharmaceuticals; termination or breach of current and future license agreements; our dependence on contract research organizations, co-promotion partners, and other outside vendors and service providers; effects of guidelines, recommendations and studies; protection of our intellectual property and avoiding intellectual property infringement; retention of key personnel; product liability; industry consolidation; compliance with environmental laws; manufacturing risks; risks and costs of international business operations; volatility of our stock price; possible dilution; absence of dividends; the extent to which COVID-19 impacts our business and the medical community; the impact of instability in general business and economic conditions, including changes in inflation, interest rates and the labor market; and other factors described in our filings with the Securities and Exchange Commission. We cannot guarantee that the results and other expectations expressed, anticipated, or implied in any forward-looking statement will be realized. A variety of factors, including these risks, could cause our actual results and other expectations to differ materially from the anticipated results or other expectations expressed, anticipated, or implied in our forward-looking statements. Should known or unknown risks materialize, or should underlying assumptions prove inaccurate, actual results could differ materially from past results and those anticipated, estimated, or projected in the forward-looking statements. You should bear this in mind as you consider any forward-looking statements. Our forward-looking statements speak only as of the dates on which they are made. We do not undertake any obligation to publicly update or revise our forward-looking statements even if experience or future changes makes it clear that any projected results expressed or implied in such statements will not be realized.
Users may only use this Site for lawful purposes, and only in their own name. Any violation or attempted violation of the security of this Site, or interference or attempted interference with the proper operation of this Site is expressly forbidden.
THE CONTENTS OF THIS SITE ARE PROVIDED “AS IS” AND WITHOUT ANY WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED, TO THE FULLEST EXTENT PERMITTED PURSUANT TO APPLICABLE LAWS. IN ADDITION, WE DO NOT WARRANT THAT YOUR USE OF, OR THE OPERATION OR FUNCTION OF, THIS SITE OR ANY LINKED SITE, ANY COMPONENT THEREOF, OR ANY SERVICES OFFERED IN CONNECTION THEREWITH, WILL BE UNINTERRUPTED OR ERROR FREE; THAT ANY DEFECTS OR ERRORS WILL BE CORRECTED; OR THAT THIS SITE OR ANY LINKED SITE OR ITS SERVERS ARE FREE OF VIRUSES OR OTHER HARMFUL ELEMENTS. IN ADDITION, CERTAIN INFORMATION (INCLUDING STOCK QUOTES) IS PROVIDED BY OR UPDATED FROM SOURCES OTHER THAN US AND EXCEPT AS OTHERWISE PROVIDED UNDER APPLICABLE LAW, WE DO NOT ASSUME ANY LIABILITY OR RESPONSIBILITY FOR THE ACCURACY OF SUCH INFORMATION. WE ARE NOT LIABLE FOR ANY DAMAGES WHATSOEVER, INCLUDING DIRECT, SPECIAL, INDIRECT, CONSEQUENTIAL, OR PUNITIVE DAMAGES, OR FOR DAMAGES FOR LOST PROFITS OR BUSINESS INTERRUPTION, RESULTING FROM ANY USE OF OR RELIANCE ON, THE MATERIALS PROVIDED IN THIS SITE OR ANY LINKED SITE, EVEN IF WE ARE NOTIFIED IN ADVANCE OF THE POTENTIAL FOR ANY SUCH DAMAGES.
We reserve the right to correct any errors, omissions, and any other inaccuracies, and to update or change information at any time without prior notice. This Site is operated by EyePoint from its offices in Watertown, Massachusetts, and these terms and conditions are governed by and shall be construed in accordance with the laws of the Commonwealth of Massachusetts, without regard to any conflict of law provisions.